Nanoscale Coordination Polymers for Anticancer Drug Delivery
Public DepositedAdd to collection
You do not have access to any existing collections. You may create a new collection.
Downloadable Content
Download PDFCitation
MLA
Phillips, Rachel Huxford. Nanoscale Coordination Polymers for Anticancer Drug Delivery. University of North Carolina at Chapel Hill, 2013. https://doi.org/10.17615/z4fz-mg46APA
Phillips, R. (2013). Nanoscale Coordination Polymers for Anticancer Drug Delivery. University of North Carolina at Chapel Hill. https://doi.org/10.17615/z4fz-mg46Chicago
Phillips, Rachel Huxford. 2013. Nanoscale Coordination Polymers for Anticancer Drug Delivery. University of North Carolina at Chapel Hill. https://doi.org/10.17615/z4fz-mg46- Last Modified
- March 22, 2019
- Creator
-
Phillips, Rachel Huxford
- Affiliation: College of Arts and Sciences, Department of Chemistry
- Abstract
- This dissertation reports the synthesis and characterization of nanoscale coordination polymers (NCPs) for anticancer drug delivery. Nanoparticles have been explored in order to address the limitations of small molecule chemotherapeutics. NCPs have been investigated as drug delivery vehicles as they can exhibit the same beneficial properties as the bulk metal-organic frameworks as well as interesting characteristics that are unique to nanomaterials. Gd-MTX (MTX = methotrexate) NCPs with a MTX loading of 71.6 wt% were synthesized and stabilized by encapsulation within a lipid bilayer containing anisamide (AA), a small molecule that targets sigma receptors which are overexpressed in many cancer tissues. Functionalization with AA allows for targeted delivery and controlled release to cancer cells, as shown by enhanced efficacy against leukemia cells. The NCPs were doped with Ru(bpy) (bpy = 2,2'-bipyridine), and this formulation was utilized as an optical imaging agent by confocal microscopy. NCPs containing the chemotherapeutic pemetrexed (PMX) were synthesized using different binding metals. Zr-based materials could not be stabilized by encapsulation with a lipid bilayer, and Gd-based materials showed that PMX had degraded during synthesis. However, Hf-based NCPs containing 19.7 wt% PMX were stabilized by a lipid coating and showed in vitro efficacy against non-small cell lung cancer (NSCLC) cell lines. Enhanced efficacy was observed for formulations containing AA. Additionally, NCP formulations containing the cisplatin prodrug disuccinatocisplatin were prepared; one of these formulations could be stabilized by encapsulation within a lipid layer. Coating with a lipid layer doped with AA rendered this formulation an active targeting agent. The resulting formulation proved more potent than free cisplatin in NSCLC cell lines. Improved NCP uptake was demonstrated by confocal microscopy and competitive binding assays. Finally, a Pt(IV) oxaliplatin prodrug was synthesized and incorporated in different NCPs using various binding metals. A moderate drug loading of 44.9 wt% was determined for Zr-based NCPs. This drug loading, along with a diameter less than 200 nm, make these particles promising candidates for further stabilization via lipid encapsulation.
- Date of publication
- May 2013
- Keyword
- DOI
- Resource type
- Rights statement
- In Copyright
- Advisor
- Lin, Wenbin
- Degree
- Doctor of Philosophy
- Graduation year
- 2013
- Language
- Publisher
Relations
- Parents:
This work has no parents.